BG60055B2 - Метод за получаване на 1-карба(детиа)цефалоспорини - Google Patents

Метод за получаване на 1-карба(детиа)цефалоспорини

Info

Publication number
BG60055B2
BG60055B2 BG089758A BG8975889A BG60055B2 BG 60055 B2 BG60055 B2 BG 60055B2 BG 089758 A BG089758 A BG 089758A BG 8975889 A BG8975889 A BG 8975889A BG 60055 B2 BG60055 B2 BG 60055B2
Authority
BG
Bulgaria
Prior art keywords
free radical
carba
methylcephalosporin
dioxide
substituted
Prior art date
Application number
BG089758A
Other languages
English (en)
Inventor
Larry Blaszczak
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG60055B2 publication Critical patent/BG60055B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/02—Preparation
    • C07D463/04—Preparation by forming the ring or condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/02—Preparation
    • C07D463/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Методът намира приложение във фармацевтичната промишленост за получаване на 1-карба(детиа)-цефалоспоринови антибиотици по бърз начин. 2-субституиран метилцефалоспорин 1,1-диоксид чрез свободно радикалов процес директно се превръща в желания продукт. Заместителят в 2-субституирания метилцефалоспорин е източник на свободен радикал, например фенилселенова група. По метода диоксидът се обработва с инициатор на свободен радикал, например триалкилкалаен хидрид, в инертен разтворител при температура 45 и 1500с. 7 претенции
BG089758A 1988-09-16 1989-09-14 Метод за получаване на 1-карба(детиа)цефалоспорини BG60055B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/245,185 US4939249A (en) 1988-09-16 1988-09-16 Process for 1-carba(dethia) cephalosporins

Publications (1)

Publication Number Publication Date
BG60055B2 true BG60055B2 (bg) 1993-08-30

Family

ID=22925647

Family Applications (1)

Application Number Title Priority Date Filing Date
BG089758A BG60055B2 (bg) 1988-09-16 1989-09-14 Метод за получаване на 1-карба(детиа)цефалоспорини

Country Status (21)

Country Link
US (1) US4939249A (bg)
EP (1) EP0359540A3 (bg)
JP (1) JPH02121987A (bg)
KR (1) KR900004738A (bg)
CN (1) CN1025620C (bg)
AU (1) AU618624B2 (bg)
BG (1) BG60055B2 (bg)
CA (1) CA1338785C (bg)
DD (1) DD284235A5 (bg)
DK (1) DK456289A (bg)
FI (1) FI93359C (bg)
HU (1) HU206716B (bg)
IL (1) IL91632A (bg)
MX (1) MX17550A (bg)
NZ (1) NZ230640A (bg)
PH (1) PH25984A (bg)
PL (1) PL161999B1 (bg)
PT (1) PT91704B (bg)
RO (1) RO105573B1 (bg)
RU (1) RU1830070C (bg)
ZA (1) ZA896992B (bg)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453502A (en) * 1994-03-16 1995-09-26 Eli Lilly And Company 1,3,4 substituted and bicyclic derivatives of 2-azetidinones and processes for preparation thereof
US5571910A (en) * 1994-12-09 1996-11-05 Schering Corporation Process for the preparation of intermediates useful in the synthesis of cephalosporins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660395A (en) * 1970-03-04 1972-05-02 Lilly Co Eli Thioether cephalosporin compounds
US3660396A (en) * 1970-03-04 1972-05-02 Lilly Co Eli Cephalosporin intermediates and process therefor
JPS5936914B2 (ja) * 1978-06-24 1984-09-06 協和醗酵工業株式会社 セフアロスポリン類縁体
EP0124081A3 (en) * 1983-05-02 1986-11-26 Merck & Co. Inc. New substituted cephalosporin sulfones as antiinflammatory and antidegenerative agents, pharmaceutical compositions containing the same and processes for making them

Also Published As

Publication number Publication date
DK456289A (da) 1990-03-17
PT91704A (pt) 1990-03-30
EP0359540A3 (en) 1991-09-04
AU618624B2 (en) 1992-01-02
PL161999B1 (pl) 1993-08-31
KR900004738A (ko) 1990-04-12
FI93359B (fi) 1994-12-15
RO105573B1 (ro) 1992-09-25
EP0359540A2 (en) 1990-03-21
DK456289D0 (da) 1989-09-15
NZ230640A (en) 1992-02-25
FI894326A0 (fi) 1989-09-13
FI93359C (fi) 1995-03-27
US4939249A (en) 1990-07-03
HUT52505A (en) 1990-07-28
CA1338785C (en) 1996-12-10
FI894326A (fi) 1990-03-17
HU206716B (en) 1992-12-28
CN1041593A (zh) 1990-04-25
RU1830070C (ru) 1993-07-23
AU4138689A (en) 1990-04-05
JPH02121987A (ja) 1990-05-09
IL91632A0 (en) 1990-04-29
ZA896992B (en) 1991-05-29
DD284235A5 (de) 1990-11-07
IL91632A (en) 1994-10-21
CN1025620C (zh) 1994-08-10
PH25984A (en) 1992-01-13
MX17550A (es) 1993-11-01
PT91704B (pt) 1995-05-31

Similar Documents

Publication Publication Date Title
HUT48218A (en) Process for producing novel, optically active imidazole derivatives
NO883793L (no) Fremgangsmaate for fremstilling av nye aristeromycin/adenosinderivater.
GB8729542D0 (en) Upper part of two-part piston for i c engines & process for production thereof
HUT43831A (en) Process for production of derivatives of 1,2,3,4-tetrahydro-6-substituated-4-aryl or heterocyclic 3-substituated-2-tioxoor oxo-5-piramidine-carbonic acid and esther
AR243139A1 (es) Metodo para el pretratamiento de materias primas para la formacion de vidrio y aparato para llevarlo a cabo.
FI92195C (fi) Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
BG60055B2 (bg) Метод за получаване на 1-карба(детиа)цефалоспорини
CS189872B1 (en) Derivatives of pyrido/1,2a/pyrimidine and process for preparing thereof
AU7833887A (en) An improved method for producing composite ceramic structures using dross
CS274612B2 (en) Method of substituted 1,3,4,9-tetrahydropyrano (3,4-b) indol-1-acetic acids production
HUT47272A (en) Process for production of derivatives of pirid, pirasole and izotriasole-triazin
DE3855002D1 (de) Verfahren zur Herstellung von Dodecahydro-3a,6,6,9a-tetramethylnaphto(2,1-b)furan
HUT47932A (en) Process for producing dihydropyridines anellated with carbocyclic and heterocyclic ring, as well as pharmaceuticals comprising same
IL82695A0 (en) Process for penam derivatives
FI906084A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 5-(2-metyyli-4,4,4-trifluoributyylikarbamoyyli)indolijohdannaisten valmistamiseksi
ZA876182B (en) 2.3-dihydrofuran derivatives,process for preparing them,and their use as an intermediate for the preparation of tetrahydrofuran derivatives
NO177348C (no) Fremgangsmåte til fremstilling av et cefalosporin-antibiotikum, samt 3-(fluorsulfonyl)oksy-substituerte cefemer og karbacefemer
PH23992A (en) Optically active 2,3-dihydrobenzoxazine derivatives and process for preparing the same
UA5548A1 (uk) Спосіб отримання похідних ізоксазолу
KR870700627A (ko) 세팔로스포린 유도체의 신규 제조방법
IL82936A0 (en) Pyrrolinone derivatives,process for the preparation thereof and the use thereof for the preparation of tetramic acid
HUT45980A (en) Process for production of derivatives of 5-hidroxi-pgf-below-alpha-1,5-lactone
EP0246605A3 (en) Conversion of aristeromycin into cyclaradine
EP0295576A3 (en) Process for the production of the derivatives of 1,3,2-oxazaphosphorinane
HU896486D0 (en) Process for the photochemical modification of cephalospirin, 1-carba(1-dethia) cephalospirin and 1-oxa(1-dethia) cephalospirin derivatives